Full Breakdown
NIH Director Signals Shift Away from DEI Funding
1/1/2026, 10:44:53 AM
Overview of the Current Situation
The National Institutes of Health (NIH) is experiencing a significant shift in its funding priorities, particularly concerning diversity, equity, and inclusion (DEI) research. Following legal challenges against the Trump administration's directives that halted numerous DEI-related projects, NIH Director Jay Bhattacharya has indicated that grants restored due to these legal decisions may not be renewed in the coming year.
Legal Background and Restoration of Grants
In June 2025, two lawsuits filed against the Trump administration resulted in the restoration of over 2,000 terminated NIH grants. A federal district judge ruled that the administration's directives to deprioritize DEI-related research were arbitrary and discriminatory. This ruling led to the reinstatement of funding for many projects that had been paused. Recently, an agreement was reached to evaluate stalled grant proposals individually, allowing for the funding of more than 135 grants that had been on hold.
Bhattacharya's Statements on DEI Funding
In a recent podcast, Jay Bhattacharya stated that while the NIH cannot cut the grants that were restored due to legal pressure, they will not renew these grants as they no longer align with NIH's current priorities. He emphasized, “Look, uh, we are not interested in funding DEI anymore.” This statement raises questions about the future of DEI-related research at the NIH, particularly for projects that were forced to be restored but do not meet the agency's new priorities.
Changes in NIH Funding Priorities
The NIH's funding process has increasingly been influenced by political considerations. In August 2025, Bhattacharya outlined new research priorities, and in December, NIH program officers received directives to align their grant portfolios with these priorities. This shift has led to researchers and NIH staff renegotiating projects to avoid terms that may be flagged by political appointees. The December guidance emphasized that renegotiation should not merely involve changing wording but should reflect a substantive shift in focus.
Criticism and Opposition
Critics of the NIH's new direction argue that the deprioritization of DEI research undermines efforts to address health disparities and inequities. The legal battles that restored funding highlight the contentious nature of these policies, with some viewing the NIH's current stance as a regression in the fight for equitable health research.
Conflicting Reports & Gaps
While Bhattacharya's comments suggest a definitive move away from DEI funding, it remains unclear how this will affect the stalled proposals currently under review. The NIH has not clarified whether these proposals will be evaluated under the new priorities or if they will face similar challenges as the previously restored grants.
What's Next
As the NIH navigates this transition, the agency will continue to evaluate grant applications in light of its new priorities. The implications of these changes for future research funding and the broader impact on health equity remain to be seen.
